Golden Age Health
Michel Vounatsos is a seasoned executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Co-founder and Executive Chairman of Golden Age Health since March 2023, Vounatsos previously held key leadership roles at Biogen, including Chief Executive Officer and Executive Vice President, Chief Commercial Officer from April 2016 to November 2022. Prior to this, Vounatsos had a lengthy tenure at Merck, where notable positions included President of Primary Care and Customer Centricity, and Chairman and President of MSD China among others, spanning from April 1996 to April 2016. Vounatsos began a professional career at Ciba-Geigy as Head of Scientific Office from September 1992 to February 1996. Educational credentials include an MBA from HEC Paris and a CSCT in Medicine from Université de Bordeaux.
This person is not in any teams
This person is not in any offices
Golden Age Health
Golden Age Health (GAH) is a fast-growing pharma platform dedicated to accelerating patient access to life-changing therapies for rare and specialty diseases in high-unmet-need markets. Led by former C-suite executives from Biogen, Merck, and other global leaders, we bridge the gap between proven innovators and the 2 billion people living in China, Asia and the Middle East. What sets us apart - Rare disease launch experience – Our team has done the most successful rare disease launches in China and Asia including Spinraza by Biogen. - End-to-end commercialization – From dossier preparation to supply-chain management, omnichannel medical engagement, and real-world evidence generation, we own the entire value chain. - Flexible deal structures – Up-front + milestone, distribution & promotion, profit-share, or JV—our models fit partners of every size. - Data-driven execution – Real-world data and AI-powered analytics drive precise patient-finding, adherence programs, and pricing strategies. - Pan-regional reach – One platform, three regions: mainland China + Hainan Pilot Zone, key ASEAN markets, and leading Gulf Cooperation Council (GCC) countries.